Cell cycle inhibition to treat sleeping sickness

INIS

• cell cycle 100%
• reductases 83%
• pathogens 66%
• inhibition 66%
• drugs 50%
• parasites 50%
• animals 33%
• in vitro 33%
• growth 33%
• trypanosomiasis 33%
• genetics 16%
• cancer 16%
• in vivo 16%
• humans 16%
• synthesis 16%
• dna 16%
• host 16%
• toxicity 16%
• malignancies 16%
• conversion 16%
• leukemia 16%
• density 16%
• blood 16%
• chemotherapy 16%
• enzymes 16%
• virulence 16%
• trypanosoma 16%
• trypanosomes 16%

Medicine and Dentistry

• Cell Cycle 100%
• Ribonucleotide Reductase 83%
• Infection 66%
• Pathogen 66%
• African Trypanosomiasis 50%
• Development 33%
• Exercise 33%
• In Vitro 33%
• Growth 33%
• Survival 33%
• Virulence Factor 16%
• Leukemia 16%
• Enzyme 16%
• Hematologic Malignancy 16%
• Chemotherapeutic Agent 16%
• Drug 16%
• Cancer Chemotherapy 16%
• Host 16%
• Drug Toxicity 16%
• Trypanosoma Brucei 16%
• Blood 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Ribonucleotide Reductase 83%
• Infection 66%
• Infectious Agent 66%
• Parasite 50%
• African Trypanosomiasis 50%
• Animal 33%
• Survival 33%
• DNA 16%
• Enzyme 16%
• Leukemia 16%
• Hematologic Malignancy 16%
• Human 16%
• Protozoon 16%
• Virulence Factor 16%
• Drug Toxicity 16%
• Trypanosoma 16%
• Drug 16%
• Eukaryote 16%
• Trypanosoma Brucei 16%
• Ribonucleotide 16%
• Host 16%
• Drug Discovery 16%